Content about Company Legal Issues

May 10, 2012
Watson seeks approval for generic ulcerative colitis drug

Generic drug maker Watson Pharmaceuticals is hoping to be the first to market a generic version of a drug used to treat ulcerative colitis, the company said.

May 8, 2012
NCPA seeks legislative relief to the business challenges faced by community pharmacy

Community pharmacy operators are the "canary in the coal mine" when it comes to federal or state prescription programs, said Douglas Hoey, CEO for the National Community Pharmacists Association, during a press conference held Tuesday afternoon.

April 30, 2012
Merck wins patent infringement suits against Mylan

Mylan will be barred from marketing a generic version of a Merck cardiovascular drug until the drug's patent expires, under a court ruling announced Friday.

April 3, 2012
Watson seeks approval for generic Lumigan, Latisse

Watson is challenging the patent protection on two eye drugs made by Allergan, the generic drug maker said Tuesday.

March 28, 2012
Three generic versions of psychiatric drug launched

Three companies have launched generic versions of a psychiatric drug made by AstraZeneca following a court decision turning down the Anglo-Swedish drug maker's request for an injunction against the Food and Drug Administration's approval of the generics.

March 26, 2012
Court dismisses AstraZeneca case against FDA

A federal court has dismissed a case that drug maker AstraZeneca filed against regulators regarding a drug used to treat psychotic and bipolar disorders, the company said Monday.

March 19, 2012
Watson challenges Abbott patent on Niaspan

Watson Pharmaceuticals is challenging the patent protection on a drug made by Abbott for treating cholesterol, the company said.

March 16, 2012
Amerigen joins Bystolic patent challenge

Another generic drug maker has joined efforts to challenge the patent on a drug made by Forest Labs for treating hypertension.

March 14, 2012
Forest files suit over generic versions of hypertension drug

Forest Labs has filed suit against Glenmark Generics and several other companies, alleging that they infringed on its patent for a drug to treat hypertension by seeking regulatory approval for generic versions.

February 29, 2012
Federal court upholds DEA action against Cardinal Health

A federal district court has turned down a request by Cardinal Health for an injunction against the Drug Enforcement Administration's suspension of the company's license to ship painkiller drugs from one of its distribution centers, the company said Wednesday.

February 21, 2012
Mylan resolves defamation suit against Pittsburgh Post-Gazette, two reporters

Mylan on Friday announced that the company and its subsidiary, Mylan Pharmaceuticals, have resolved the defamation and other related litigation filed by Mylan against the Pittsburgh Post-Gazette and two of its reporters.

February 14, 2012
Mylan to challenge court decision over generic asthma, COPD drug

Generic drug maker Mylan plans to challenge a court decision that requires it to pay almost $20 million to a drug company whose product it tried to market as a generic.

February 8, 2012
Watson, J&J settle lawsuit over generic contraceptive

Subsidiaries of Watson Pharmaceuticals and Johnson & Johnson have settled a lawsuit filed by the latter when Watson attempted to market a generic version of one of its contraceptive drugs.

January 27, 2012
Watson, Mallinckrodt settle over generic painkiller

Watson Pharmaceuticals and Mallinckrodt have reached a settlement concerning a painkiller for which the former had sought Food and Drug Administration approval.

January 9, 2012
Mylan seeks approval for generic diabetes drug

Generic drug maker Mylan is challenging the patent on a drug used to treat diabetes, the company said Monday.

November 21, 2011
Impax Labs looks to market generic cancer pain drug

Drug maker Impax Labs is looking to challenge the patent protection on a drug used to treat pain related to cancer, the company said Monday.

November 11, 2011
Appeals court rejects Teva request to stop Watson from selling generic Seasonique

An appeals court has thrown out an attempt by Teva Pharmaceutical Industries to stop Watson Pharmaceuticals from selling a generic contraceptive, Watson said.

November 11, 2011
Watson files for approval of generic dementia treatment

Watson Pharmaceuticals is challenging Swiss drug maker Novartis' patent on a drug used to treat dementia, Watson said.

November 8, 2011
Express Scripts amends Medco merger agreement; lowers termination fee

In an amendment dated Nov. 7 and filed to the Securities Exchange Commission on Tuesday, Express Scripts reduced its termination fee by 32% to $650 million.

November 2, 2011
Perrigo seeks approval for generic version of Abbott's Androgel

Drug maker Perrigo has filed for regulatory approval of a generic topical drug for treating testosterone deficiency, prompting a patent infringement suit from the branded version's manufacturer.

October 17, 2011
Watson seeks approval for generic ADHD treatment

Generic drug maker Watson Pharmaceuticals is seeking Food and Drug Administration approval for a generic treatment for attention deficit hyperactivity disorder, the company said.

October 7, 2011
Watson files for approval of generic painkiller

Watson Pharmaceuticals is looking to become the first to market a generic version of a painkiller made by Pfizer, the drug maker said Friday.

October 6, 2011
Perrigo receives tentative FDA approval for generic scalp dermatosis drug

The Food and Drug Administration has granted tentative approval to a drug made by Perrigo for dermatosis of the scalp.

October 4, 2011
Report: Supreme Court rejects Mylan appeal

Mylan must pay $77 million to four health insurers over allegations that it sought to control the market on ingredients used for two anti-anxiety medicines, according to published reports.

September 16, 2011
Walgreens, ESI dispute moves to arbitration following court decision

U.S. District Court judge Marvin Aspen ruled in favor of Walgreens on Thursday; Express Scripts' federal suit against Walgreens will be halted pending arbitration.

© 2012 Drug Store News. All Rights Reserved.